iThera Medical leads the field of optoacoustic imaging (OAI) technology for preclinical and clinical research. OAI utilizes the photoacoustic effect - light energy absorbance resulting in acoustic signal emission - to visualize and quantify rich optical contrast in deep tissue, at high spatiotemporal resolution.
OAI allows the study of disease-related changes in tissue composition on an anatomical, functional and molecular level as well as the analysis of pharmacokinetic and biodistribution properties for diagnostic and therapeutic substances.
Recently, OAI has been translated from preclinical research towards clinical use. It promises to become a broadly applicable diagnostic technique across a wide range of indications, including various types of cancer, cardiovascular, inflammatory, fibrotic and metabolic diseases.
